UnitedHealth's 2025 guidance reflects optimism with expected revenue growth of 13% and EPS growth of 7%, aiming for a "normal ...
UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...
The KraneShares Value Line Dynamic Dividend Equity ETF is a value-oriented core fund that emphasizes higher dividends, stable ...
UnitedHealth Group has experienced a significant decline in its stock price, falling 25.7% from its November 2024 peak. The healthcare giant’s recent struggles stem from missing Q4 revenue estimates .
Amedisys has not provided financial guidance due to the pending acquisition by UnitedHealth Group ... their earnings estimates upward for the upcoming period. For more detailed insights and additional ...
Amedisys has not provided financial guidance due to the pending acquisition by UnitedHealth Group (NYSE:UNH). The acquisition’s impact on the company’s future financial performance remains ...
UnitedHealth Group has been a trending stock ... Despite this downturn, analysts focus on key factors such as earnings estimates and revenue growth to determine its future trajectory. Earnings ...
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc. (UNH ... poised for growth in the future. Adjusted net earnings per share are anticipated ...
The company's forward price-to-earnings (P ... traditional insurance segment, as well as generating a higher operating margin. Additionally, the services UnitedHealth Group provides aren't going ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results